Rofecoxib does not inhibit aberrant crypt foci formation but inhibits later steps in the development of experimental colorectal cancer: rofecoxib in experimental colon cancer.
about
Rofecoxib does not inhibit aberrant crypt foci formation but inhibits later steps in the development of experimental colorectal cancer: rofecoxib in experimental colon cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Rofecoxib does not inhibit abe ...... in experimental colon cancer.
@en
Rofecoxib does not inhibit abe ...... in experimental colon cancer.
@nl
type
label
Rofecoxib does not inhibit abe ...... in experimental colon cancer.
@en
Rofecoxib does not inhibit abe ...... in experimental colon cancer.
@nl
prefLabel
Rofecoxib does not inhibit abe ...... in experimental colon cancer.
@en
Rofecoxib does not inhibit abe ...... in experimental colon cancer.
@nl
P2093
P2860
P1476
Rofecoxib does not inhibit abe ...... in experimental colon cancer.
@en
P2093
Anton Cerar
Martina Perse
P2860
P356
10.1080/00365520410009519
P577
2005-01-01T00:00:00Z